Chemotherapy for Advanced Neuroendocrine Tumors (NETs): Patient Selection Should be Independent of Primary Tumor Site

#902

Introduction: Chemotherapy (CT) is used to treat patients (pts) with advanced poorly-differentiated (Pd); or well-differentiated (Wd) NETs with high-tumor burden (usually of pancreatic (pNET) origin).

Aim(s): Retrospective analysis

Materials and methods: Patients with advanced NETs receiving CT were identified. Stata.12 was used.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Lamarca A, Hubner R, Mansoor W, Valle J,

Keywords: chemotherapy, advanced neuroendocrine tumors,